Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.
All recreational drug use ballot initiatives failed in the 2024 elections. Only one medical marijuana measure passed in ...
Substance Use Treatment Facilities examined data from SAMHSA and other sources to see how teen drug use varies across the U.S ...